Expansion of the medical cannabis market in Brazil and regulatory challenges.
作者信息
Pinto Cláudia Du Bocage Santos, Esher Ângela, Oliveira Cátia Verônica Dos Santos, Osorio-de-Castro Claudia Garcia Serpa
机构信息
Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brasil.
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.
出版信息
Cad Saude Publica. 2024 Dec 20;40(11):e00088624. doi: 10.1590/0102-311XEN088624. eCollection 2024.
Abstract
摘要
相似文献
1
Expansion of the medical cannabis market in Brazil and regulatory challenges.
Cad Saude Publica. 2024 Dec 20;40(11):e00088624. doi: 10.1590/0102-311XEN088624. eCollection 2024.
2
The Cannabis Gray Market: A Case for Cannabis Regulatory Science Research.
Cannabis Cannabinoid Res. 2025 Feb;10(1):6-10. doi: 10.1089/can.2023.0278. Epub 2024 Jul 1.
3
Perspectives on formation of medical cannabis market in Ukraine based on holistic approach.
J Cannabis Res. 2020 Oct 2;2(1):33. doi: 10.1186/s42238-020-00044-y.
4
Healthcare Professionals' Perceptions About Medical Cannabis in Greece: A Qualitative Study.
J Mark Access Health Policy. 2025 Apr 2;13(2):13. doi: 10.3390/jmahp13020013. eCollection 2025 Jun.
5
Implications of the 2018 Canadian Cannabis Act: Should regulation differ for medicinal and non-medicinal cannabis use?⋆.
Health Policy. 2021 Jan;125(1):12-16. doi: 10.1016/j.healthpol.2020.10.016. Epub 2020 Nov 11.
6
Issues in the establishment of a therapeutic cannabis market under Jamaica's Dangerous Drugs Amendment Act 2015.
Int J Drug Policy. 2020 Sep 15;86:102945. doi: 10.1016/j.drugpo.2020.102945.
7
L. from Seized Drug Material: Germination and Establishment.
Cannabis Cannabinoid Res. 2024 Jun;9(3):e924-e932. doi: 10.1089/can.2022.0305. Epub 2023 Aug 23.
8
Association of recreational cannabis legalization with changes in medical, illegal, and total cannabis expenditures in Canada.
Int J Drug Policy. 2025 May;139:104793. doi: 10.1016/j.drugpo.2025.104793. Epub 2025 Apr 5.
9
Medical cannabis laws lower individual market health insurance premiums.
Int J Drug Policy. 2023 Sep;119:104143. doi: 10.1016/j.drugpo.2023.104143. Epub 2023 Aug 10.
10
Bridging the gap: Exploring consumer experiences and motivations for transitioning between illicit and regulated cannabis markets.
Int J Drug Policy. 2024 Dec;134:104644. doi: 10.1016/j.drugpo.2024.104644. Epub 2024 Nov 2.
本文引用的文献
1
Medical cannabis for children: Evidence and recommendations.
Paediatr Child Health. 2024 Apr 5;29(2):104-121. doi: 10.1093/pch/pxad078. eCollection 2024 May.
2
On activism and knowledge: the experience of cannabis associations in Brazil.
Cien Saude Colet. 2024 Feb;29(2):e18462022. doi: 10.1590/1413-81232024292.18462022. Epub 2023 May 17.
3
[Judicialization of cannabidiol-based products in Brazil: an analysis from 2019 to 2022].
Cad Saude Publica. 2023 Oct 9;39(8):e00024723. doi: 10.1590/0102-311XPT024723. eCollection 2023.
4
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
BMJ. 2023 Aug 30;382:e072348. doi: 10.1136/bmj-2022-072348.
5
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
BMC Med. 2022 Aug 19;20(1):259. doi: 10.1186/s12916-022-02459-1.
6
Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies.
BMJ Open. 2022 Aug 4;12(8):e054282. doi: 10.1136/bmjopen-2021-054282.
7
"Is medical cannabis safe for my patients?" A practical review of cannabis safety considerations.
Eur J Intern Med. 2021 Jul;89:10-18. doi: 10.1016/j.ejim.2021.05.002. Epub 2021 May 31.
8
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8.
Zotero 插件